Product Information

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID is a generic product labeled by Endo USA Inc., priced at $0.0778 per ML under NDC 00603154358. Its NADAC has been published 580 times since Jul 15, 2015.

FDA first approved this application on Dec 22, 2014. Its Orange Book therapeutic-equivalence code is AA.

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID

Potassium Chloride
$0.0778per ML
Discontinued

Strength

40 meq/15mL

Manufacturer

Endo USA Inc.

NDC

00603154358

Classification

Generic

Dosage Form

SOLUTION

Route

ORAL

Effective Date

8/19/2026

Active Ingredients

POTASSIUM CHLORIDE

Approval Type

New Drug (NDA)

FDA Application

NDA206814

FDA Approved

12/22/2014

TE Code

AA

On Market Since

5/4/2015

Pharmacological Classes

Increased Large Intestinal Motility
Inhibition Large Intestine Fluid/Electrolyte Absorption
Osmotic Activity
Osmotic Laxative
Potassium Compounds
Potassium Salt

Price Statistics

The NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has been published 580 times since Jul 15, 2015, and over the history we have for it it has declined 32.6%. The table below summarizes its recorded NADAC range and movement.

Current price$0.0778 per ML
All-time high$0.9714 (Nov 16, 2016)
All-time low$0.0440 (Dec 17, 2025)
52-week high$0.0778
52-week low$0.0440
Median price$0.5055
Average price$0.4618
Largest weekly change+199.3% (Oct 21, 2015)
Weeks tracked580
Tracking sinceJul 15, 2015

Price History

1W

+10.7%

1M

+38.5%

3M

+73.9%

6M

+54.9%

1Y

+17.8%

3Y

-63.6%

5Y

-89.0%

All

-32.6%

Generic Alternatives

No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Potassium Chloride market page.

Lowest-Cost Alternatives

No alternatives available

No alternatives found with the same active ingredient and strength in a comparable dosage form.

Frequently asked questions

What is the NADAC price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

The current National Average Drug Acquisition Cost (NADAC) for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID, manufactured by Endo USA Inc., is $0.0778 per ML (NDC 00603154358), effective Aug 19, 2026.

How has the price of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID changed over time?

Over the history we have for it, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has declined 32.6%. It has been tracked across 580 weekly CMS publications since Jul 15, 2015.

What are the highest and lowest recorded NADAC prices for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

Since Jul 15, 2015, the NADAC for POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID has ranged from a low of $0.0440 (Dec 17, 2025) to a high of $0.9714 (Nov 16, 2016), with a median of $0.5055 per ML.

Are there cheaper alternatives to POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

No other NADAC-published product currently shares the active ingredient and strength of POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID in a comparable dosage form, so no direct lower-cost alternative is listed.

Who manufactures POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID?

POTASSIUM CHLORIDE 20% (40 MEQ/15 ML) ORAL LIQUID (NDC 00603154358) is labeled by Endo USA Inc., and CMS classifies it as a generic product.